Federal Government to Test GenoMed's Approach to the Flu: Could Counter Vaccine Shortage

Article

ST. LOUIS  -- GenoMed, Inc. announced that the National Institute of Allergy and Infectious Disease (NIAID), a member institute of the National Institutes of Health, has expressed interest in testing GenoMeds approach to the flu using an animal model.

GenoMed has applied for patent protection on the use of a class of blood pressure medications in viral diseases, including the flu. This is a totally novel approach. There is no shortage of these medications worldwide.

The federal government has expressed interest in broad-spectrum viral antidotes. GenoMed met last week with federal government officials to discuss GenoMeds potential broad-spectrum viral antidote and further testing of its approach against viral diseases, including influenza. The meeting resulted in an expansion of the contract which GenoMed originally signed with NIAID in December 2003.

SOURCE: GenoMed, Inc.

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content